explore -WSS

explore

author：focus 2025-10-02 22:28:24 - browse：38786

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth.

At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021. This process, known as accelerated approval, required the company to run a confirmatory study. But ahead of an advisory panel meeting on Thursday, the agency released documents showing its staff found “potential systemic bias” in the trial.

The disclosure throws into question the future of this drug, which has offered hope to patients for whom an effective treatment previously seemed out of reach. Some Wall Street analysts are now betting the FDA will ask Amgen to run yet another trial or maybe withdraw the drug altogether. Either way, the prognosticators are reworking their calculus for Amgen stock.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Why the Crimean Bridge is key to Russia's war in Ukraine

WSS

Stanford updates investigation of president’s past research

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

What AstraZeneca

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

hotspot

explore

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why the Crimean Bridge is key to Russia's war in Ukraine

New air purifier tech could be key to improving indoor air quality

What AstraZeneca

Medicare details structure of new drug price negotiation program

Couple fighting to bring baby home from Mexico are finally reunited

Tori Bowie and the unacceptable rates of Black maternal death

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

How to save PrEP access — and even expand it

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Wikipedia

India sets sights on home

Stanford president to resign after investigation of research

Teacher posts viral 'school supply rant' with advice for parents

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Russian and Belarusian players banned from a women's tennis tournament in Prague

Poland's lawmakers approve a divisive law on Russian influence

entertainment

Wikipedia

focus

focus